First Clinical Trial Under Novartis' Beacon of Hope Set to Launch
The first clinical trial under Novartis’s 10-year, multimillion dollar Beacon of Hope collaboration with 26 Historically Black Colleges is set to launch at Morehouse School of Medicine.
Morehouse is the first institution to establish a clinical trial center of excellence under the Beacon of Hope program, which seeks to address systemic health disparities across the research and medical development ecosystem and increase diversity in clinical trial participants and investigators.
The Morehouse Center’s first clinical trial is in LDL-C management, key to addressing a high coronary heart disease mortality rate among African Americans.
Read more about the trial and expansion here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
